Navigation Links
Questcor Reports Fourth Quarter and Full Year 2012 Results
Date:2/26/2013

nd Investor Communications The company will host a conference call and slide presentation via webcast today, February 26, 2013, at 4:30 p.m. ET/ 1:30 p.m. PT. The call can be accessed three ways:

  • By webcast: At Questcor's investor relations website, http://ir.questcor.com/.
  • By telephone: For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is (877) 354-0215. For participants outside the U.S., the dial-in number is (253) 237-1173.
  • By audio replay: A replay of the conference call will be available for seven business days following conclusion of the live call. The dial-in number for U.S. participants is (855) 859-2056. For participants outside the U.S., the replay dial-in number is (404) 537-3406. The replay access code for all callers is 95427085.
  • About QuestcorQuestcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications. Of these 19 indications, Questcor currently generates substantially all of its net sales from the following on-label indications: the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of prote
    '/>"/>

    SOURCE Questcor Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
    2. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
    3. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
    4. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
    5. Questcor to Conduct Conference Call to Discuss Reimbursement Process
    6. Questcor Comments on Insurance Policy Bulletin
    7. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
    8. Questcor Pharmaceuticals to Present at Investor Conferences in September
    9. Questcor Reports Second Quarter Financial Results
    10. Questcor to Report Second Quarter Results on July 24, 2012
    11. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ... "Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ ... Competitors and Opportunities: 2015 - 2020 Analysis and ... Pain is defined as an unpleasant sensory ... tissue damage. At some point, everyone experiences pain. ...
    (Date:8/30/2015)... y LONDRES, August 30, 2015 ... holística de l cuidado al paciente ... trayecto   Royal Philips  ... europeo de IntelliSpace Cardiovascular , un sistema web ... herramientas para acceder, analizar y compartir imágenes cardiovasculares e ...
    (Date:8/28/2015)... -- With the heroin epidemic in the United ... -based Lakeview Health drug and alcohol treatment center,s ... why fentanyl is causing a new wave of overdoses. ... potent than pharmaceutical grade heroin and often illegally purchased ... death skyrockets. "Fentanyl can be an important ...
    Breaking Medicine Technology:Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
    ... Inc. announced today that it has entered into a ... based Astellas Pharma Inc., providing Agensys with access to ... of identifying antibodies with enhanced antibody-dependent cellular cytotoxicity (ADCC). ... Agreement with Agensys, a leading monoclonal antibody organization with ...
    ... 14, 2010 Pfizer Inc. (NYSE: PFE ... a statistically significant reduction in risk of cardiovascular (CV) ... chronic heart failure with mild symptoms treated with Inspra ... to standard HF therapy.  The results were presented to ...
    Cached Medicine Technology:BioWa Announces License of POTELLIGENT® Technology to Agensys 2Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows 2Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows 3Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows 4Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows 5Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows 6
    (Date:8/31/2015)... New York, NY (PRWEB) , ... August 31, ... ... on Malignant Mesothelioma is a one-day event geared to patients and family ... and presented by local and regional mesothelioma experts. The conference is a collaborative ...
    (Date:8/31/2015)... ... August 31, 2015 , ... Coast Dental Vista is ... from 11 a.m. to 3 p.m. near Albertsons in the Foothill Center, located at ... Dr. Ofelia Rivera and Dr. Jay Lopp. Call (760) 208-2518 for more details or ...
    (Date:8/31/2015)... ... September 01, 2015 , ... Neuropsychiatric Disease and Treatment ... on transcranial near-infrared laser phototherapy ”. , As corresponding author Dr Theodore Henderson ... untreatable - with mostly palliative treatments only - and now we have shown ...
    (Date:8/31/2015)... ... ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved ... Betsy graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He earned ... in his senior year. He was inducted into the National Honor Society as a ...
    (Date:8/31/2015)... ... August 31, 2015 , ... How can ... others—to hold down costs? , In a commentary for The American Journal ... the concept of “clinical efficacy,” which would bind parties together in agreements to ...
    Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3
    ... over the declaration to be issued after today's UN meet ... to effectively contain the epidemic that has claimed 25 million ... to be issued, UN Secretary General Kofi Annan asked diplomats ... in 2001., ,The UNGA's session hoped to arrive at ...
    ... Cross (Indonesia), Mark Snelling, explains about relief operations in earthquake ... ,Over 5,700 were died and more than a thousand were ... that even 24 hours here is an eternity – said ... totally collapsed and 200,000 lost their homes. ,The ...
    ... on manslaughter by doctors in UK, says that many were ... Walker was found to be convicted //but the Journal of ... ,Due to vengeance and retribution, Birmingham City Hospital ... 1795. ,Because of vaginal wound and the ...
    ... and Emergency Medicine is being held in Delhi later ... and US doctors.// The objective of this conference is ... need for specialty faculties for emergency medicine and disaster ... Consulate here Wednesday to launch preparation for the Second ...
    ... has decided to suspend a ban on smoking in public ... of controversy//. The court ordered that the ban be suspended ... authority to order such a ban. ,The companies, ... annpo8unced just seven days ago before it came into effect ...
    ... have 'a long way to go' before fully understanding ... will remain a concern 'for years to come'//. ... officials from the Food and Agriculture Organisation (FAO) and ... bird migrations and the illegal trade in infected animals ...
    Cached Medicine News:Health News:New Delhi to Host Conference on Accident & Emergency Medical Treatment 2Health News:Brid Flu Threat May be a Cause of Concern for Years to Come: Experts 2
    ... 2 adjustable belt buckle. You adjust once and ... off your shoulders. And now theres our Lady ... anatomy. ,For additional back support try one of ... on the vertebrae and help lift the apron ...
    ... Genesis Total Knee System provides the adaptability ... each patient. Not the other way around. ... articular inserts and patellar components allow surgeons ... And you do it all with one ...
    ... System will define the state of knee ... less - reducing inventory requirements and increasing ... and cost situations. The GENESIS II femoral ... creative solutions tomeet todays surgical demands. Clinical ...
    ... knee system was designed ... polyethylene wear between all ... contact stress associated with ... a well balanced knee ...
    Medicine Products: